-
Space development conference held in Beijing E-Town to boost commercial aerospace industry
2025-02-18
The 2nd Beijing Commercial Space High-Quality Development Conference was held at the Tongming Lake Convention and Exhibition Center in the city's Economic-Technological Development Area (Beijing E-Town) on Feb 12.
-
UBtech becomes China's first listed humanoid robot company
2025-02-18
UBtech, which has its humanoid robot headquarters in the Beijing E-Town, has been listed on The Humanoid 100: Mapping the Humanoid Robot Value Chain released by Morgan Stanley, making it China's first humanoid robot listed company.
-
Beijing E-Town becomes a leading high-end industrial comprehensive new city
2025-02-18
To achieve the goal of promoting the regional GDP in the area to break through 500 billion yuan by 2030, Kong stated that Beijing E-Town will put efforts on building a modern industrial system with distinctive local characteristics and promoting livelihood projects.
-
Beijing E-Town further constructs fund system
2025-02-18
The Beijing Economic Development Area (Beijing E-Town) completed the registration and establishment of the Industrial Upgrading Equity Investment Fund Phase II on Feb 10, marking an important step forward in the construction of the fund system.
-
Beijing E-Town's aerospace industry blooms
2025-02-18
In 2024, the scale of E-Town's aerospace industry exceeded 35 billion yuan ($4.82 billion).
-
Beijing E-Town to create a better business environment
2025-02-14
Beijing E-Town is determined to provide full lifecycle services for enterprises and streamlining the entire municipal approval process.
-
Largest industrial CT testing center in the northern China to be completed
2025-02-14
The research and production project of Royma Optoelectronics Technology, located in Beijing E-Town, is expected to be completed by October this year. Upon completion, it will be the largest industrial CT testing center in northern China.
-
Six foreign pharmaceutical companies establish new R&D institutions in E-Town
2025-02-14
In 2024, eight well-known foreign pharmaceutical companies have established new research and development institutions in Beijing, with six of them choosing to settle at the BioPark in Beijing Economic-Technological Development Area (Beijing E-Town), further deepening their business layout in China.